![]() QGel QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics. | ![]() Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. | |
Founding Date | Founding Date 2009 | Founding Date 2015 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Lausanne, CH HQ | Locations Lexington, US HQ South Wharf, AU |
Employees | Employees 147% decrease | Employees 7854% decrease |
Funding | ||
Total funding raised | Total funding raised $ 12m | Total funding raised $ 90m |

Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company